CardiolRx

Drug identity checked against registry records

Also recorded as Cannabidiol; Pharmaceutically produced Cannabidiol; Pharmaceutically produced cannabidiol

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisNCT05180240CRDLPhase 2Completed2025-01-31Actual
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)NCT05494788CRDLPhase 2Completed2024-06-15Actual
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299CRDLPhase 3Recruiting2026-09-21Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.